Robert Driscoll

Stock Analyst at Wedbush

(2.16)
# 2,932
Out of 5,044 analysts
151
Total ratings
35.34%
Success rate
-1.3%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Robert Driscoll

Corbus Pharmaceuticals Holdings
Oct 20, 2025
Maintains: Outperform
Price Target: $31$38
Current: $16.86
Upside: +125.39%
Replimune Group
Oct 20, 2025
Upgrades: Outperform
Price Target: $4$18
Current: $10.21
Upside: +76.30%
Revolution Medicines
Oct 17, 2025
Reiterates: Outperform
Price Target: $77
Current: $58.02
Upside: +32.71%
Crescent Biopharma
Jul 14, 2025
Initiates: Outperform
Price Target: $27
Current: $12.50
Upside: +116.00%
Kura Oncology
Jun 20, 2025
Reiterates: Outperform
Price Target: $36
Current: $10.26
Upside: +250.88%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Neutral
Price Target: $4
Current: $1.53
Upside: +161.44%
Werewolf Therapeutics
May 9, 2025
Maintains: Outperform
Price Target: $8$6
Current: $1.56
Upside: +284.62%
Monte Rosa Therapeutics
Mar 21, 2025
Maintains: Outperform
Price Target: $15$17
Current: $12.50
Upside: +36.00%
Arvinas
Mar 12, 2025
Downgrades: Neutral
Price Target: $57$12
Current: $9.59
Upside: +25.13%
Day One Biopharmaceuticals
Feb 26, 2025
Reiterates: Outperform
Price Target: $32
Current: $7.04
Upside: +354.55%
Reiterates: Outperform
Price Target: $52
Current: $32.18
Upside: +61.59%
Reiterates: Outperform
Price Target: $28
Current: $15.24
Upside: +83.73%
Reiterates: Outperform
Price Target: $16
Current: $3.82
Upside: +318.85%
Reiterates: Outperform
Price Target: $30
Current: $20.29
Upside: +47.86%
Reiterates: Outperform
Price Target: $5
Current: $0.75
Upside: +566.22%
Reiterates: Outperform
Price Target: $36
Current: $7.69
Upside: +368.14%
Reiterates: Outperform
Price Target: $11
Current: $1.45
Upside: +658.62%
Reiterates: Outperform
Price Target: $13
Current: $4.23
Upside: +207.33%
Maintains: Outperform
Price Target: $11$13
Current: $7.85
Upside: +65.61%
Reiterates: Outperform
Price Target: $74
Current: $27.81
Upside: +166.09%
Reiterates: Outperform
Price Target: $8
Current: $3.78
Upside: +111.64%
Reiterates: Outperform
Price Target: $7
Current: $1.23
Upside: +469.11%
Upgrades: Outperform
Price Target: $3$8
Current: $3.26
Upside: +145.40%
Upgrades: Outperform
Price Target: $2$4
Current: $4.61
Upside: -13.23%